Cassava Sciences Inc vs Direxion Daily Semiconductor Bear 3X Shares — how do they compare? Cassava Sciences Inc trades at $1.08 (market cap $53.14M), while Direxion Daily Semiconductor Bear 3X Shares trades at $51. Which is the better fit depends on your goals.
| FLNA | SOXS | |
|---|---|---|
Market Cap | $53.14M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $4.64 | $1.61K |
52-Week Low | $1.09 | $32.50 |
Enterprise Value | -$33.43M | — |
Signals from Pluang's Aura AI — not financial advice
Filana Therapeutics (FLNA) trades at $1.09, down 5.22% on the day, reflecting persistent operational losses despite recent earnings beats. The stock exhibits a strong bearish technical signal, with moving averages and oscillators aligned negatively. Fundamentally, the company is in a pre-revenue biotech development phase, evidenced by significant negative cash flow from operations (-$32.25M in 2025) and deeply negative profitability metrics (ROE: -79.59%). Recent news highlights continued focus on its Tuberous Sclerosis Complex (TSC)-related epilepsy program.
The outlook is bifurcated: a bullish analyst consensus (8 Buy, 4 Hold, 0 Sell) suggests optimism for the clinical pipeline, while severe financial burn and bearish technicals present substantial near-term risk. Investment opportunity hinges entirely on successful drug development, with significant dilution or financing risk as the company funds operations. The stock is suitable only for high-risk investors comfortable with binary clinical outcomes.
SOXS, the Direxion Daily Semiconductor Bear 3X Shares ETF, surged 19.91% to $50.96 as semiconductor stocks faced pressure from competitive threats. The ETF shows a bullish technical signal with strong moving average support but overbought RSI readings. Recent corporate actions include a 1:10 stock split scheduled for July 2026 and a $0.04 dividend payment in June 2026. The fund provides 3x leveraged inverse exposure to the semiconductor sector, benefiting from recent market volatility.
SOXS offers tactical exposure to semiconductor sector declines but carries significant risks due to its leveraged structure and the strong fundamental support for AI-driven chip demand. The ETF's performance remains highly dependent on semiconductor market volatility rather than traditional company fundamentals. Investors should be cautious of decay effects and the challenging environment for bearish semiconductor positioning given current industry momentum.
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →SOXS is a leveraged ETF that seeks daily investment results corresponding to 300% of the inverse (opposite) of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bearish (short) position on the semiconductor sector. Due to the effects of compounding and leverage, SOXS is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXS →